Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TFRC-RNA interactions show the regulation of gene expression and alternative splicing associated with IgAN in human renal tubule mesangial cells. | Front Genet | 2023 | 37547464 | PubTator, text mining | PubMed |
| SPI1 involvement in malignant melanoma pathogenesis by regulation of HK2 through the AKT1/mTOR pathway. | J Cell Mol Med | 2023 | 37539493 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Small molecule targeting of transcription-replication conflict for selective chemotherapy. | Cell Chem Biol | 2023 | 37531956 | PubTator, text mining | PubMed |
| Unveiling the prognostic significance of SOX5 in esophageal squamous cell carcinoma: a comprehensive bioinformatic and experimental analysis. | Aging (Albany NY) | 2023 | 37531195 | PubTator, text mining | PubMed |
| Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas. | Front Endocrinol (Lausanne) | 2023 | 37529607 | PubTator, text mining | PubMed |
| Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. | Turk J Biol | 2023 | 37529110 | PubTator, text mining | PubMed |
| Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets. | FEBS Open Bio | 2023 | 37517032 | PubTator, text mining | PubMed |
| Aberrant AHRR, ADAMTS2 and FAM184 DNA Methylation: Candidate Biomarkers in the Oral Rinse of Heavy Smokers. | Biomedicines | 2023 | 37509437 | PubTator, text mining | PubMed |
| The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. | Biomolecules | 2023 | 37509175 | PubTator, text mining | PubMed |
| Disruption of the Mammalian Ccr4-Not Complex Contributes to Transcription-Mediated Genome Instability. | Cells | 2023 | 37508532 | PubTator, text mining | PubMed |
| How Pol α-primase is targeted to replisomes to prime eukaryotic DNA replication. | Mol Cell | 2023 | 37506699 | PubTator, text mining | PubMed |
| The minichromosome maintenance complex drives esophageal basal zone hyperplasia. | JCI Insight | 2023 | 37490338 | PubTator, text mining | PubMed |
| A direct interaction between CENTLEIN and RABIN8 is required for primary cilium formation. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37475549 | PubTator, text mining | PubMed |
| Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family. | BMC Cancer | 2023 | 37464398 | PubTator, text mining | PubMed |
| Changing protein-DNA interactions promote ORC binding-site exchange during replication origin licensing. | Proc Natl Acad Sci U S A | 2023 | 37463200 | PubTator, text mining | PubMed |
| Metabolic clogging of mannose triggers dNTP loss and genomic instability in human cancer cells. | Elife | 2023 | 37461317 | PubTator, text mining | PubMed |
| In Silico Characterization of RNASEH2A Pathogenic Variants and Identification of Novel Splice Site Donor Variant c.549+1G>T in Indian Population. | Cureus | 2023 | 37456470 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma. | Iran J Med Sci | 2023 | 37456201 | PubTator, text mining | PubMed |
| UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells. | FEBS Open Bio | 2023 | 37454373 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=10